Rockwell Medical (NASDAQ:RMTI) Upgraded to Buy at StockNews.com

StockNews.com upgraded shares of Rockwell Medical (NASDAQ:RMTI) from a hold rating to a buy rating in a research report report published on Thursday morning.

Several other research firms have also weighed in on RMTI. HC Wainwright cut their target price on Rockwell Medical from $9.00 to $7.00 and set a “buy” rating on the stock in a research note on Monday, November 25th. Rodman & Renshaw initiated coverage on shares of Rockwell Medical in a research report on Thursday, November 14th. They issued a “buy” rating and a $5.00 price target on the stock. Finally, RODMAN&RENSHAW upgraded shares of Rockwell Medical to a “strong-buy” rating in a report on Thursday, November 14th.

Rockwell Medical Stock Performance

RMTI stock opened at $2.07 on Thursday. Rockwell Medical has a twelve month low of $1.16 and a twelve month high of $5.15. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 2.00. The business’s fifty day moving average is $3.06 and its 200-day moving average is $2.68.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Armistice Capital LLC lifted its holdings in shares of Rockwell Medical by 22.5% during the 2nd quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock valued at $5,670,000 after purchasing an additional 592,000 shares in the last quarter. Jane Street Group LLC acquired a new stake in Rockwell Medical during the 3rd quarter worth approximately $534,000. Walleye Capital LLC bought a new position in Rockwell Medical in the third quarter valued at approximately $435,000. Renaissance Technologies LLC boosted its holdings in shares of Rockwell Medical by 877.1% in the second quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock valued at $181,000 after buying an additional 92,189 shares during the period. Finally, Corsair Capital Management L.P. bought a new stake in shares of Rockwell Medical during the third quarter worth $298,000. 23.31% of the stock is owned by institutional investors and hedge funds.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.